AI assistant
AbbVie Inc. — Director's Dealing 2018
Dec 13, 2018
29755_dirs_2018-12-12_b0d9780e-bce0-4a59-b52a-7cbfb61047fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2018-12-10
Reporting Person: Stewart Jeffrey Ryan (SVP, US Commercial Operations)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 29478 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option (right to buy) | $51.42 | 2024-02-19 | Common stock (25290) | Direct | |
| Option (right to buy) | $58.88 | 2025-02-18 | Common stock (27690) | Direct | |
| Option (right to buy) | $54.86 | 2026-02-17 | Common stock (21810) | Direct | |
| Option (right to buy) | $61.36 | 2027-02-15 | Common stock (26110) | Direct | |
| Option (right to buy) | $114.36 | 2028-02-14 | Common stock (16070) | Direct |
Footnotes
F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 8,430 shares on 2/20/2015, as to 8,430 shares on 2/20/2016 and as to 8,430 shares on 2/20/2017.
F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 9,230 shares on 2/19/2016, as to 9,230 shares on 2/19/2017 and as to 9,230 shares on 2/19/2018.
F3: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 7,270 shares on 2/18/2017 and as to 7,270 shares on 2/18/2018, and becomes exercisable as to 7,270 shares on 2/18/2019.
F4: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 8,704 shares on 2/16/2018, and becomes exercisable as to 8,703 shares on 2/16/2019 and as to 8,703 shares on 2/16/2020.
F5: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable as to 5,357 shares on 2/15/2019, as to 5,356 shares on 2/15/2020 and as to 5,357 shares on 2/15/2021.